CFM
SRDX

Catalyst Funds Management’s Surmodics SRDX Stock Holding History

Catalyst Funds Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,340
Closed -$303K – 1569
2024
Q1 		$303K Buy
+10,340
New +$330K 0.08% 193

Other funds holding SRDX

BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Catalyst Funds Management's SRDX Position: Q2 2024 in Review

Catalyst Funds Management sold out of Surmodics (SRDX) in Q2 2024, closing a stake of 10,340 shares — an estimated $303K sold.

Catalyst Funds Management first reported a position in SRDX in Q1 2024 and held it in 1 quarter. The position peaked at $303K in Q1 2024. 124 funds tracked by Wall St. Rank hold SRDX as of Q2 2024.

  • Catalyst Funds Management reported no remaining Surmodics position as of Q2 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 10,340 Surmodics shares in Q2 2024, an estimated $303K.
  • Catalyst Funds Management first reported a position in Surmodics in Q1 2024 and held it in 1 quarter.
  • Catalyst Funds Management's Surmodics position peaked at $303K in Q1 2024.
  • 124 funds tracked by Wall St. Rank held Surmodics as of Q2 2024.

Based on Catalyst Funds Management's 13F filing for Q2 2024, filed 18 Dec 2024.